Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Durvalumab 1500, Small Cell Lung Cancer

Protocol-ID: 2651 V1.0 (Mini), DURV1500, SCLC

Indication(s)

  • Lung Carcinoma, Small Cell; ICD-10 C34.-

Links

  • Spigel DR; ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC). [ASCO Abstracts doi]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 13.06.2024